• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PHF19 介导的前列腺癌细胞增殖和侵袭的调控。

PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells.

机构信息

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Universitat Pompeu Fabra (UPF), Barcelona, Spain.

出版信息

Elife. 2020 Mar 10;9:e51373. doi: 10.7554/eLife.51373.

DOI:10.7554/eLife.51373
PMID:32155117
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7064337/
Abstract

The Polycomb-like protein PHF19/PCL3 associates with PRC2 and mediates its recruitment to chromatin in embryonic stem cells. PHF19 is also overexpressed in many cancers. However, neither PHF19 targets nor misregulated pathways involving PHF19 are known. Here, we investigate the role of PHF19 in prostate cancer cells. We find that PHF19 interacts with PRC2 and binds to PRC2 targets on chromatin. PHF19 target genes are involved in proliferation, differentiation, angiogenesis, and extracellular matrix organization. Depletion of PHF19 triggers an increase in MTF2/PCL2 chromatin recruitment, with a genome-wide gain in PRC2 occupancy and H3K27me3 deposition. Transcriptome analysis shows that PHF19 loss promotes deregulation of key genes involved in growth, metastasis, invasion, and of factors that stimulate blood vessels formation. Consistent with this, silencing reduces cell proliferation, while promotes invasive growth and angiogenesis. Our findings reveal a role for PHF19 in controlling the balance between cell proliferation and invasiveness in prostate cancer.

摘要

多梳样蛋白 PHF19/PCL3 与 PRC2 相关,并在胚胎干细胞中介导其向染色质的募集。PHF19 在许多癌症中也过表达。然而,PHF19 的靶标或涉及 PHF19 的失调途径都不清楚。在这里,我们研究了 PHF19 在前列腺癌细胞中的作用。我们发现 PHF19 与 PRC2 相互作用,并与染色质上的 PRC2 靶标结合。PHF19 的靶基因参与增殖、分化、血管生成和细胞外基质组织。PHF19 的缺失会触发 MTF2/PCL2 染色质募集的增加,同时全基因组范围内 PRC2 占据和 H3K27me3 沉积增加。转录组分析表明,PHF19 的缺失会促进与生长、转移、侵袭以及刺激血管形成的关键基因的失调。与此一致的是,沉默会降低细胞增殖,同时促进侵袭性生长和血管生成。我们的研究结果揭示了 PHF19 在控制前列腺癌中细胞增殖和侵袭之间平衡的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0b378286a77b/elife-51373-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/7b1f7bffefa4/elife-51373-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0684d8f0c0f9/elife-51373-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/df9146c45d4e/elife-51373-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/ed88b7c73f04/elife-51373-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/9e22b177b3f3/elife-51373-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/dbccff3070f7/elife-51373-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/7ddbd44fa13c/elife-51373-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0c890a078693/elife-51373-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/ded949f4c9bc/elife-51373-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0a44d44b1fcf/elife-51373-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/6296b58b6049/elife-51373-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0b378286a77b/elife-51373-fig6-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/7b1f7bffefa4/elife-51373-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0684d8f0c0f9/elife-51373-fig1-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/df9146c45d4e/elife-51373-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/ed88b7c73f04/elife-51373-fig2-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/9e22b177b3f3/elife-51373-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/dbccff3070f7/elife-51373-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/7ddbd44fa13c/elife-51373-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0c890a078693/elife-51373-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/ded949f4c9bc/elife-51373-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0a44d44b1fcf/elife-51373-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/6296b58b6049/elife-51373-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c8a4/7064337/0b378286a77b/elife-51373-fig6-figsupp1.jpg

相似文献

1
PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells.PHF19 介导的前列腺癌细胞增殖和侵袭的调控。
Elife. 2020 Mar 10;9:e51373. doi: 10.7554/eLife.51373.
2
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation.PHF19 通过激活 PRC2 和广泛形成 H3K27me3 结构域促进多发性骨髓瘤的肿瘤发生。
Blood. 2019 Oct 3;134(14):1176-1189. doi: 10.1182/blood.2019000578. Epub 2019 Aug 5.
3
An H3K36 methylation-engaging Tudor motif of polycomb-like proteins mediates PRC2 complex targeting.多梳样蛋白的 H3K36 甲基化结合 Tudor 基序介导 PRC2 复合物的靶向。
Mol Cell. 2013 Feb 7;49(3):571-82. doi: 10.1016/j.molcel.2012.11.026. Epub 2012 Dec 27.
4
A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin.一种用于 PRC2-PCL 靶向 CpG 岛染色质的二聚体结构支架。
Mol Cell. 2020 Mar 19;77(6):1265-1278.e7. doi: 10.1016/j.molcel.2019.12.019. Epub 2020 Jan 17.
5
Downregulation of PHF19 inhibits cell growth and migration in gastric cancer.PHF19的下调抑制胃癌细胞的生长和迁移。
Scand J Gastroenterol. 2020 Jun;55(6):687-693. doi: 10.1080/00365521.2020.1766555. Epub 2020 May 23.
6
Structural basis for histone variant H3tK27me3 recognition by PHF1 and PHF19.组蛋白变体 H3tK27me3 被 PHF1 和 PHF19 识别的结构基础。
Elife. 2020 Sep 1;9:e58675. doi: 10.7554/eLife.58675.
7
Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation.多梳 PHF19 结合 H3K36me3,并在分化过程中招募 PRC2 和去甲基酶 NO66 到胚胎干细胞基因上。
Nat Struct Mol Biol. 2012 Dec;19(12):1273-81. doi: 10.1038/nsmb.2449. Epub 2012 Nov 18.
8
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer.从 PHF19 在癌症中作用的分析中深入了解高危多发性骨髓瘤。
J Exp Clin Cancer Res. 2021 Dec 2;40(1):380. doi: 10.1186/s13046-021-02185-1.
9
PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis.PHF19 通过调节 SIAH1/β-catenin 轴促进脑胶质瘤对阿霉素的增殖、迁移和化疗敏感性。
Cell Death Dis. 2018 Oct 15;9(11):1049. doi: 10.1038/s41419-018-1082-z.
10
Polycomb-like Proteins in Gene Regulation and Cancer.多梳样蛋白在基因调控和癌症中的作用
Genes (Basel). 2023 Apr 18;14(4):938. doi: 10.3390/genes14040938.

引用本文的文献

1
Transcript PHF19-207 May Be a Long Non-Coding RNA with Tumor-Promoting Role in Colon Cancer.转录本PHF19-207可能是一种在结肠癌中具有促肿瘤作用的长链非编码RNA。
Biomolecules. 2025 Jul 2;15(7):957. doi: 10.3390/biom15070957.
2
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.基于多组学和人工智能驱动的女性恶性肿瘤表观遗传治疗药物重新定位
J Transl Med. 2025 Jul 25;23(1):837. doi: 10.1186/s12967-025-06856-x.
3
WTAP-mediated mA methylation of PHF19 facilitates cell cycle progression by remodeling the accessible chromatin landscape in t(8;21) AML.

本文引用的文献

1
The Complexity of PRC2 Subcomplexes.PRC2 亚基复合物的复杂性。
Trends Cell Biol. 2019 Aug;29(8):660-671. doi: 10.1016/j.tcb.2019.05.004. Epub 2019 Jun 6.
2
Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment.去势抵抗性前列腺癌:机制、靶点与治疗。
Adv Exp Med Biol. 2018;1096:117-133. doi: 10.1007/978-3-319-99286-0_7.
3
PHF19 promotes the proliferation, migration, and chemosensitivity of glioblastoma to doxorubicin through modulation of the SIAH1/β-catenin axis.PHF19 通过调节 SIAH1/β-catenin 轴促进脑胶质瘤对阿霉素的增殖、迁移和化疗敏感性。
WTAP介导的PHF19的m⁶A甲基化通过重塑t(8;21)急性髓系白血病中可及的染色质景观促进细胞周期进程。
Oncogene. 2025 Jun;44(20):1504-1516. doi: 10.1038/s41388-025-03329-9. Epub 2025 Mar 4.
4
Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study.基于调节性T细胞的肾细胞癌分类的构建与验证:一项综合生物信息学分析和临床队列研究
Cell Oncol (Dordr). 2024 Dec 23. doi: 10.1007/s13402-024-01030-9.
5
EZH2 directly methylates PARP1 and regulates its activity in cancer.EZH2 直接甲基化 PARP1 并调节其在癌症中的活性。
Sci Adv. 2024 Nov 29;10(48):eadl2804. doi: 10.1126/sciadv.adl2804. Epub 2024 Nov 27.
6
Epigenetic (De)regulation in Prostate Cancer.前列腺癌中的表观遗传(去)调控。
Cancer Treat Res. 2023;190:321-360. doi: 10.1007/978-3-031-45654-1_10.
7
Polycomb-like Proteins in Gene Regulation and Cancer.多梳样蛋白在基因调控和癌症中的作用
Genes (Basel). 2023 Apr 18;14(4):938. doi: 10.3390/genes14040938.
8
Critical Roles of Polycomb Repressive Complexes in Transcription and Cancer.多梳抑制复合物在转录和癌症中的关键作用。
Int J Mol Sci. 2022 Aug 24;23(17):9574. doi: 10.3390/ijms23179574.
9
DNA binding by polycomb-group proteins: searching for the link to CpG islands.多梳蛋白家族通过与 DNA 结合:寻找与 CpG 岛的联系。
Nucleic Acids Res. 2022 May 20;50(9):4813-4839. doi: 10.1093/nar/gkac290.
10
Evolutionary adaptation of the Polycomb repressive complex 2.多梳抑制复合物 2 的进化适应。
Epigenetics Chromatin. 2022 Feb 22;15(1):7. doi: 10.1186/s13072-022-00439-6.
Cell Death Dis. 2018 Oct 15;9(11):1049. doi: 10.1038/s41419-018-1082-z.
4
Promoter bivalency favors an open chromatin architecture in embryonic stem cells.启动子二价有利于胚胎干细胞中开放染色质结构。
Nat Genet. 2018 Oct;50(10):1452-1462. doi: 10.1038/s41588-018-0218-5. Epub 2018 Sep 17.
5
microRNA-124a suppresses PHF19 over-expression, EZH2 hyper-activation, and aberrant cell proliferation in human glioma.miRNA-124a 抑制 PHF19 过表达、EZH2 过度激活和人神经胶质瘤中的异常细胞增殖。
Biochem Biophys Res Commun. 2018 Sep 10;503(3):1610-1617. doi: 10.1016/j.bbrc.2018.07.089. Epub 2018 Aug 18.
6
miR-211 sponges lncRNA MALAT1 to suppress tumor growth and progression through inhibiting PHF19 in ovarian carcinoma.微小RNA-211通过海绵吸附长链非编码RNA MALAT1,抑制卵巢癌中的PHF19,从而抑制肿瘤生长和进展。
FASEB J. 2018 Jun 6:fj201800495RR. doi: 10.1096/fj.201800495RR.
7
MTF2 recruits Polycomb Repressive Complex 2 by helical-shape-selective DNA binding.MTF2 通过螺旋形选择性 DNA 结合招募 Polycomb 抑制复合物 2。
Nat Genet. 2018 Jul;50(7):1002-1010. doi: 10.1038/s41588-018-0134-8. Epub 2018 May 28.
8
A Family of Vertebrate-Specific Polycombs Encoded by the LCOR/LCORL Genes Balance PRC2 Subtype Activities.LCOR/LCORL 基因编码的脊椎动物特异性 Polycomb 家族平衡 PRC2 亚基活性。
Mol Cell. 2018 May 3;70(3):408-421.e8. doi: 10.1016/j.molcel.2018.03.005. Epub 2018 Apr 5.
9
Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential.EZH2对癌症进展的表观遗传调控:从生物学见解到治疗潜力
Biomark Res. 2018 Mar 9;6:10. doi: 10.1186/s40364-018-0122-2. eCollection 2018.
10
is a driver of aggressive prostate cancer by promoting invasion, cell fate and cytoskeleton alterations and epithelial to mesenchymal transition.通过促进侵袭、细胞命运和细胞骨架改变以及上皮-间质转化,是侵袭性前列腺癌的一个驱动因素。
Oncotarget. 2018 Jan 10;9(7):7604-7615. doi: 10.18632/oncotarget.24123. eCollection 2018 Jan 26.